Indwelling Pleural Catheters Market Size, Sales, Average Price and Trends Analysis, till 2032

Indwelling Pleural Catheters Market Size is estimated to be $170million in 2024 and is expected to grow at an average yearly rate of around 7% during the timeframe (2025-2032).

Monitor Country-wise Indwelling Pleural Catheters Sales and Demand with Our Comprehensive Indwelling Pleural Catheters Sales Database

Gain in-depth insights into the Indwelling Pleural Catheters Sales landscape across 20+ countries with our specialized Indwelling Pleural Catheters Sales Database. Stay ahead in the market by tracking country-wise Indwelling Pleural Catheters Sales, identifying key manufacturers.

Extensive Indwelling Pleural Catheters Sales database covering 20+ countries worldwide, Indwelling Pleural Catheters Sales trends

Indwelling Pleural Catheters market revenue tracker by country

Stay Updated with Indwelling Pleural Catheters Sales Trends

Track real-time Indwelling Pleural Catheters prices, analyze Indwelling Pleural Catheters price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Indwelling Pleural Catheters Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/indwelling-pleural-catheters-market/


Indwelling Pleural Catheters sales trend in 2024 vs 2025

The global market for Indwelling Pleural Catheters (IPCs) has shown consistent growth over recent years, driven by increasing demand for minimally invasive treatments for pleural effusions. In comparing the sales trends of 2024 and 2025, a notable upward trajectory can be observed, with various clinical, technological, and demographic factors contributing to the expansion of this medical device segment.


In 2024, the demand for IPCs remained robust, primarily fueled by rising cases of malignant pleural effusion (MPE), which often occurs in patients with late-stage cancers such as lung, breast, and ovarian cancer. IPCs allow for long-term fluid drainage without repeated hospital visits, making them a highly attractive option for palliative care. Sales in 2024 were also driven by increased awareness among physicians and patients regarding the benefits of IPCs over traditional methods like repeated thoracentesis or chemical pleurodesis. Hospitals and clinics expanded their use of IPCs due to lower complication rates, ease of insertion, and the possibility of home management.


By 2025, the sales trend continues on an upward slope, with market analysts observing a year-on-year growth rate of approximately 6-8%. This rise is attributed to both an increase in disease incidence and improvements in healthcare infrastructure, especially in emerging markets. In countries such as India, Brazil, and parts of Southeast Asia, IPC adoption is accelerating due to better training for clinicians, increased accessibility to interventional pulmonology, and improved reimbursement scenarios. The rising geriatric population, which is more susceptible to conditions that lead to pleural effusion, also contributes to this sustained demand.


Technological advancements have also played a significant role in boosting IPC sales in 2025. Manufacturers have introduced catheters with better durability, anti-kink designs, and biocompatible materials that reduce infection risk and increase patient comfort. Some models now include vacuum systems or indicators to assist caregivers and patients during home drainage procedures. These improvements have not only enhanced clinical outcomes but also improved the perception and acceptance of IPCs as a long-term management solution.


Another trend in 2025 is the increasing integration of IPC management into telehealth and remote care programs. With more patients managing IPCs at home, healthcare providers are leveraging virtual consultations and monitoring tools to ensure proper catheter use and minimize complications. This integration supports the broader healthcare shift toward outpatient and home-based care, contributing further to IPC sales growth.


Regionally, North America and Europe continue to dominate the IPC market due to their advanced healthcare systems and early adoption of medical technologies. However, Asia-Pacific is the fastest-growing region, driven by improving healthcare access, rising disease awareness, and supportive government policies for chronic disease management.

Request for customization https://datavagyanik.com/reports/indwelling-pleural-catheters-market/


Indwelling Pleural Catheters Market Definition

The Indwelling Pleural Catheters (IPC) market refers to the global industry surrounding the design, manufacturing, distribution, and application of specialized medical devices used to manage recurrent pleural effusions. Pleural effusion is a medical condition where fluid accumulates between the layers of the pleura-the tissue lining the lungs and chest cavity-causing breathing difficulty, discomfort, and reduced lung function. IPCs are soft, flexible tubes that are inserted into the pleural space and left in place to allow continuous or intermittent drainage of fluid, often at home, over extended periods. This market definition encompasses all stakeholders involved in the production, regulation, innovation, and clinical usage of these catheters.


Unlike traditional short-term treatments such as thoracentesis (a procedure where fluid is removed with a needle), IPCs offer a long-term solution, particularly for patients with recurrent effusions that result from chronic conditions like cancer, congestive heart failure, or liver disease. These catheters are especially useful in palliative care, as they reduce the need for repeated hospital visits and invasive procedures. The IPC market, therefore, includes not only the catheters themselves but also the accessories and home drainage kits that accompany them, along with services related to their insertion and management.


The market is segmented in various ways-by product type, end-user, indication, and geography. Product types generally vary by catheter size, design features such as anti-kink tubing or anti-microbial coatings, and drainage mechanisms (manual or vacuum-assisted). End-users include hospitals, ambulatory surgical centers, and home care settings. The indications most commonly associated with IPCs are malignant pleural effusion (MPE), non-malignant effusion, and empyema. From a geographic perspective, the market spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with each region presenting distinct trends in demand, regulation, and access to healthcare.


One of the key characteristics of the IPC market is its alignment with broader trends in modern healthcare, including a growing emphasis on minimally invasive procedures, cost-effective outpatient care, and patient comfort. The IPC market also benefits from technological innovation. Advancements in catheter materials, design improvements to reduce infection risks, and integrated monitoring systems are expanding the appeal and applicability of these devices.


Regulatory considerations play an important role in shaping the IPC market. These devices must comply with medical device safety standards in various jurisdictions, often requiring clinical trials and quality assurance certifications. As awareness increases and clinical guidelines evolve to support their use, IPCs are being more widely adopted in both developed and developing countries.



Important target segments driving the demand for Indwelling Pleural Catheters Market

The Indwelling Pleural Catheters (IPC) market is being shaped and driven by specific target segments that significantly contribute to the growing demand. These segments are defined by clinical need, demographic trends, and healthcare delivery models. Below are the key target segments fueling the expansion of the IPC market:

1. Patients with Malignant Pleural Effusion (MPE)

This is the most critical and dominant target segment. MPE occurs in patients with advanced-stage cancers such as lung, breast, ovarian, and mesothelioma. Since pleural effusion in these cases is recurrent and symptomatic, IPCs offer a minimally invasive, long-term solution that improves quality of life. As cancer prevalence increases globally, so does the demand for IPCs in oncology care.

2. Geriatric Population

Elderly patients are more prone to chronic illnesses like congestive heart failure, chronic kidney disease, and cancer-all of which can cause pleural effusions. IPCs are preferred for this age group because they reduce hospitalizations and allow for symptom management at home, aligning with the growing focus on aging-in-place and home healthcare.

3. Palliative Care and Hospice Patients

IPCs are ideal for patients receiving palliative or end-of-life care, where the primary goal is symptom relief rather than curative treatment. This segment values the comfort, convenience, and autonomy that IPCs offer, minimizing invasive interventions and hospital visits.

4. Home Healthcare Sector

With healthcare systems emphasizing outpatient and home-based treatments, patients who can manage IPCs at home with the support of caregivers or home nurses are becoming an important segment. Home drainage kits and remote monitoring tools are increasingly integrated into care plans, supporting this demand.

5. Patients with Non-Malignant Recurrent Pleural Effusions

Though less common than MPE, chronic pleural effusions from conditions like heart failure, liver cirrhosis, or tuberculosis also require long-term management. In selected cases, IPCs are being used as a safe and effective alternative to repeated thoracentesis or surgical procedures.

6. Hospitals and Ambulatory Surgical Centers

These institutions represent an institutional target segment, particularly as more facilities adopt IPC procedures due to lower complication rates and shorter recovery times. IPCs offer an efficient solution for managing pleural effusions without requiring extended hospital stays.

7. Emerging Healthcare Markets

Countries in Asia-Pacific, Latin America, and parts of Africa represent fast-growing demand segments due to improving healthcare access, rising disease awareness, and expanded interventional pulmonology training. These regions are transitioning toward modern, minimally invasive treatment methods, driving IPC adoption.



Key Players in Indwelling Pleural Catheters, Market Share

The Indwelling Pleural Catheters (IPC) market is characterized by the presence of several key players who contribute significantly to its growth and innovation. These companies are involved in the development, manufacturing, and distribution of IPCs, catering to the increasing demand driven by the rising prevalence of pleural effusions and the preference for minimally invasive procedures.

Major Companies in the IPC Market

Rocket Medical plc: A prominent player known for its focus on pleural drainage solutions, Rocket Medical offers a range of IPCs designed for effective management of pleural effusions.

Merit Medical Systems, Inc.: Merit Medical provides a variety of medical devices, including IPCs, emphasizing innovation and quality in their product offerings.

Becton, Dickinson and Company (BD): BD is a global medical technology company that manufactures and sells medical devices, including IPCs, contributing to the market with its extensive distribution network.

B. Braun Melsungen AG: B. Braun offers a wide range of medical products, including IPCs, and is recognized for its commitment to improving healthcare delivery.

Eakin Healthcare Group: Specializing in medical devices, Eakin Healthcare provides IPCs that are designed to enhance patient comfort and ease of use.

Medtronic: As a leading medical technology company, Medtronic's portfolio includes IPCs that are part of its broader range of respiratory and surgical solutions.

Teleflex Incorporated: Teleflex offers a variety of medical devices, including IPCs, focusing on innovation to meet the evolving needs of healthcare providers and patients.

Smiths Group plc: Through its medical division, Smiths Medical, the company provides IPCs and other critical care products, emphasizing safety and efficiency.

Cook Medical: Cook Medical develops a range of minimally invasive medical devices, including IPCs, aiming to improve patient outcomes through innovative solutions.

Coloplast A/S: Coloplast offers products for various medical conditions, including IPCs, with a focus on patient-centered care and product quality.

Market Share Insights

While specific market share percentages can vary by region and over time, these key players collectively hold a significant portion of the IPC market. Their dominance is attributed to factors such as extensive product portfolios, strong distribution channels, ongoing research and development, and strategic collaborations.

The market is also witnessing the emergence of new entrants and smaller companies that are introducing innovative IPC solutions, contributing to increased competition and diversity in product offerings. This competitive landscape encourages continuous improvement in product design, patient comfort, and overall treatment efficacy.

Key Questions Answered in the Indwelling Pleural Catheters market report:

What is the total global Indwelling Pleural Catheters Sales volume, and how has it changed over the past five years?

What is Indwelling Pleural Catheters price trend, what has been the historical prices?

What will be the Indwelling Pleural Catheters price trend in 2025?

Which countries have the highest Indwelling Pleural Catheters Sales, and what factors contribute to their dominance in the market?

How does Indwelling Pleural Catheters Sales vary across key manufacturers, and what expansions have been observed recently?

What is the current global revenue generated from Indwelling Pleural Catheters Sales, and how does it compare to previous years?

Which industries drive the highest demand for Indwelling Pleural Catheters, and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Indwelling Pleural Catheters Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Indwelling Pleural Catheters Sales and market dynamics?

Related Studies:

Aspiration Catheters for Acute Ischemic Stroke Market
https://datavagyanik.com/reports/aspiration-catheters-for-acute-ischemic-stroke-market/

Tracheal & Bronchial Bioabsorbable Stents Market
https://datavagyanik.com/reports/tracheal-bronchial-bioabsorbable-stents-market/

Colonic Stents Market
https://datavagyanik.com/reports/colonic-stents-market/

Cold Plasma Wound Treatment Market
https://datavagyanik.com/reports/cold-plasma-wound-treatment-market/

Amniotic Membrane-Based Wound Dressings for Chronic Ulcers and Burns Market
https://datavagyanik.com/reports/amniotic-membrane-based-wound-dressings-for-chronic-ulcers-and-burns-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/
Email: sales@datavagyanik.com

This release was published on openPR.